Effects of glutathione isopropyl ester on bile flow in glutathione-depleted rats. 1993

H Yoshida, and Y Kuronuma, and M Iijima, and T Tamano, and T Harada
Second Department of Internal Medicine, Dokkyo University School of Medicine, Tochigi, Japan.

Combined administration of buthionine sulfoximine (2.5 mmol/kg, i.p.) and diethyl maleate (1.0 ml/kg, i.p.) resulted in a near-complete depletion of hepatic glutathione (0.02 mumol/g liver vs 5.17 mumol/g in saline-treated controls) in male Sprague-Dawley rats. Bile flow was markedly reduced in the rats as compared with the controls and glutathione was not detected in the bile. The linear regression of the correlation between bile flow and endogenous bile-acid excretion rates revealed that no bile acid-independent bile flow was produced in the glutathione-depleted rats. The bile flow was partially restored by an intravenous infusion of glutathione isopropyl ester (1.17 mmol/kg/hr). Glutathione levels were increased in the bile (16 nmol/kg/min) and in the liver (0.55 mumol/g) at the end of the 100 min infusion period of the ester. The increments in bile flow rates were not proportional to the biliary excretion rates of bile acids or glutathione, and the flow rates suddenly increased when glutathione levels in the bile reached an apparent threshold. The increments, not accompanied with an excretion of diethyl maleate-glutathione conjugate, were much greater than expected from the osmotic choleresis of glutathione in the bile. These results indicate that hepatic glutathione above a certain level is required for the formation of a portion of bile flow, and that an intravenous administration of glutathione isopropyl ester is effective in partially restoring the bile formation impaired by glutathione depletion.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008298 Maleates Derivatives of maleic acid (the structural formula (COO-)-C
D008717 Methionine Sulfoximine Sulfoximine, Methionine
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000963 Antimetabolites Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) Antimetabolite
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D012636 Secretory Rate The amount of a substance secreted by cells or by a specific organ or organism over a given period of time; usually applies to those substances which are formed by glandular tissues and are released by them into biological fluids, e.g., secretory rate of corticosteroids by the adrenal cortex, secretory rate of gastric acid by the gastric mucosa. Rate, Secretory,Rates, Secretory,Secretory Rates

Related Publications

H Yoshida, and Y Kuronuma, and M Iijima, and T Tamano, and T Harada
April 1989, Research communications in chemical pathology and pharmacology,
H Yoshida, and Y Kuronuma, and M Iijima, and T Tamano, and T Harada
January 1990, Journal of dermatological science,
H Yoshida, and Y Kuronuma, and M Iijima, and T Tamano, and T Harada
February 1993, Current eye research,
H Yoshida, and Y Kuronuma, and M Iijima, and T Tamano, and T Harada
September 1995, Biological & pharmaceutical bulletin,
H Yoshida, and Y Kuronuma, and M Iijima, and T Tamano, and T Harada
June 1995, Research communications in molecular pathology and pharmacology,
H Yoshida, and Y Kuronuma, and M Iijima, and T Tamano, and T Harada
April 1987, Journal of applied toxicology : JAT,
H Yoshida, and Y Kuronuma, and M Iijima, and T Tamano, and T Harada
April 2000, Current eye research,
H Yoshida, and Y Kuronuma, and M Iijima, and T Tamano, and T Harada
January 1996, Photochemistry and photobiology,
H Yoshida, and Y Kuronuma, and M Iijima, and T Tamano, and T Harada
July 1987, Canadian journal of physiology and pharmacology,
H Yoshida, and Y Kuronuma, and M Iijima, and T Tamano, and T Harada
June 1990, Biochemical pharmacology,
Copied contents to your clipboard!